MedTrace Logo

Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy

NCT01881035 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-03-10

No results posted yet for this study

Summary

The study is designed to investigate the efficacy of renal nerve denervation in treating drug-resistant hypertension in patients with end stage renal disease.

Conditions

  • Hypertension Secondary to Renal Disease

Interventions

PROCEDURE

Renal nerve denervation

Renal nerve denervation is performed by catheter ablation of renal arteries influencing the sympathetic nerves.

Sponsors & Collaborators

  • Oulu University Hospital

    collaborator OTHER

  • Satakunta Central Hospital

    collaborator OTHER

  • Central Finland Hospital District

    collaborator OTHER

  • Vaasa Central Hospital, Vaasa, Finland

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-01
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881035 on ClinicalTrials.gov